Multi-omics Mendelian randomization and machine learning identify candidate therapeutic targets for Alzheimer’s and Parkinson’s diseases
Authors:
- 16 January 2026
- journal article
- research article
- Published by Springer Nature in Mammalian Genome
- Vol. 37 (1) , 24
Abstract
Neurodegenerative diseases (NDDs), including Alzheimer’s disease (AD) and Parkinson’s disease (PD), are major public health challenges lacking effective therapies. To identify potential drug targets, we integrated large-scale genome-wide association studies with expression, methylation, protein, and splicing QTL datasets using Mendelian Randomization (MR) and summary-data-based MR (SMR). Colocalization analysis and machine learning were applied to prioritize candidate genes, followed by in silico druggability evaluation through molecular docking and molecular dynamics (MD) simulations. In animal models, candidate genes identified by transcriptomic analysis were further validated using integrative molecular and functional experiments. We identified several genes with potential causal links to AD (e.g., IQCE, HDHD2, ALPP) and PD (e.g., IL15, STK3, CHRNB1). Transcriptomic analyses indicated a consistent downregulation of IL-15 in PD model mice, corroborated by subsequent Western blot and immunohistochemical validation. Among predicted compounds, Prednisolone (ALPP), Sirolimus (IL15), and CHEMBL379975 (STK3) showed favorable binding affinities and stable MD trajectories, suggesting promising therapeutic relevance. Collectively, these findings highlight 12 QTL-regulated genes as promising molecular targets for further investigation in the context of NDDs. While the computational results provide a useful basis for hypothesis generation, experimental validation will be essential to determine the biological relevance and therapeutic potential of these candidate genes and compounds.Keywords
Funding Information
- National Natural Science Foundation of China (82474605)
- Natural Science Foundation of Fujian (XJG20230163)
This publication has 66 references indexed in Scilit:
- Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control CasesFrontiers in Neuroscience, 2016
- Mendelian Randomization Studies for a Continuous Exposure Under Case-Control SamplingAmerican Journal of Epidemiology, 2015
- Inactivation of the Paraoxonase 1 Gene Affects the Expression of Mouse Brain Proteins Involved in NeurodegenerationJournal of Alzheimer’s Disease, 2014
- High-content genome-wide RNAi screens identify regulators of parkin upstream of mitophagyNature, 2013
- RNG105 Deficiency Impairs the Dendritic Localization of mRNAs for Na+/K+ATPase Subunit Isoforms and Leads to the Degeneration of Neuronal NetworksJournal of Neuroscience, 2010
- A Serial Analysis of Gene Expression Profile of the Alzheimer’s Disease Tg2576 Mouse ModelNeurotoxicity Research, 2009
- CHARMM‐GUI: A web‐based graphical user interface for CHARMMJournal of Computational Chemistry, 2008
- Circulating interleukin-15 and RANTES chemokine in Parkinson’s diseaseActa Neurologica Scandinavica, 2007
- Effect of levodopa on interleukin‐15 and RANTES circulating levels in patients affected by Parkinson′s diseaseMediators of Inflammation, 2003
- WOLFF—PARKINSON—WHITE SYNDROME AND GENERAL ANAESTHESIA: USE OF ISOFLURANE AND VECURONIUMBritish Journal of Anaesthesia, 1986